Females | |||
---|---|---|---|
ICD- 10 or ATC code | Description | NRI (%) | ORME |
U071 and U072 | COVID- 19—in hospitalized patients | 16.1 | 18.8 |
R53 | Malaise and fatigue | 14.5 | 4.6 |
G933 | Post-viral and related fatigue syndromes | 10.1 | 21.1 |
R06 | Dyspnea | 8.4 | 6.2 |
J01, J02, J03, J06 and J20 | Upper respiratory tract infections | 5.9 | 3.2 |
R43 | Disturbances of smell and taste | 4.4 | 28.9 |
B34 | Viral infection of unspecified site | 3.1 | 3.5 |
R03 A and R03B (ATC) | Adrenergics, inhalants and other drugs for obstructive airway diseases, inhalants | 2.8 | 1.8 |
R00 | Tachycardia | 2.6 | 3.0 |
F43 | Reaction to severe stress, and adjustment orders | 2.3 | 2.1 |
R05 | Cough | 2.1 | 2.3 |
R51 | Headache | 2.0 | 2.6 |
Z86 | Personal history of certain other diseases | 1.7 | 5.6 |
R50 | Fever | 1.6 | 4.4 |
F41 | Anxiety disorders | 1.6 | 1.6 |
G03 A (ATC) | Hormonal contraceptives for systemic use | 1.3 | 2.3 |
Z02 | Encounter for administrative examination | 1.0 | 2.2 |